Oral carohydrate drink on blood glucose levels in minimally invasive colorectal surgery
Not Applicable
- Conditions
- Health Condition 1: K638- Other specified diseases of intestine
- Registration Number
- CTRI/2020/08/027261
- Lead Sponsor
- Amrita Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA I, II, and III patients.
2.Undergoing minimally Invasive
(Laparoscopic and Robotic) elective colorectal surgeries.
3. Diabetic Patients whose morning FBS <200mg/dl
Exclusion Criteria
1.BMI > 35
2.Delayed gastric emptying/autonomic neuropathy
3.Intestinal obstruction.
4. Diabetic patients with FBS > 200 mgm/dL and uncontrolled sugars
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose levels prior to and during surgery following the administration of maltodextrin supplement in patients undergoing elective minimally invasive colorectal surgeryTimepoint: T0: Start of surgery <br/ ><br>T1: 2h into surgery <br/ ><br>T2: 4 h into surgery <br/ ><br>TE: End of surgery
- Secondary Outcome Measures
Name Time Method 1.Evaluation of patient comfort at induction <br/ ><br>2.Incidence of hyperglycemia or hypoglycemia and need for intervention intraoperatively <br/ ><br>3.Measurement of gastric aspirate after intubation. <br/ ><br>4.Incidence of post operative nausea and vomiting. <br/ ><br>5.Length of ICU stay <br/ ><br>Timepoint: T0: Start of surgery <br/ ><br>T1: 2 h into surgery <br/ ><br>T2: 4 H into surgery <br/ ><br>TE: end of surgery